Abnormality of the genital system
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the pinna
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acidosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
Carnitine palmitoyl transferase 2 deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Postnatal clinical course and work-up, however, revealed early, neonatal forms of disorders of fatty acid oxidation (DFAO) in both cases, namely, glutaric acidemia type II, based on identification of the novel, homozygous splice-site mutation c.1117-2A > G in the ETFDH gene, in one case and carnitine palmitoyltransferase II deficiency in the other case.
|
28083701 |
2017 |
Carnitine palmitoyl transferase 2 deficiency
|
0.020 |
Biomarker
|
disease |
BEFREE |
Genetic studies were performed to detect mutations in the SLC22A5 for primary carnitine deficiency, PNPLA2 for neutral lipid storage disease with myopathy, ABHD5 for neutral lipid storage disease with ichthyosis, ETFDH for multiple acyl-CoA dehydrogenation deficiency (MADD), and CPT2 for carnitine palmitoyltransferase II deficiency.
|
20370797 |
2010 |
COENZYME Q10 DEFICIENCY
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.
|
17412732 |
2007 |
Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Congenital hypoplasia of lung
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Depressed nasal bridge
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysmorphic facies
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electron transfer flavoprotein-ubiquinone oxidoreductase defect
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Erythrocyte Mean Corpuscular Hemoglobin Test
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Ethylmalonic aciduria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fatigue
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Siblings with the common myopathic ETFDH c.1130T>C mutation presented with a new phenotype dominated by chronic fatigue without apparent myopathy.
|
31331668 |
2019 |
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Finding of Mean Corpuscular Hemoglobin
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Generalized aminoaciduria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gliosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Glutaric acidemia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
GLUTARIC ACIDEMIA IIC
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
GLUTARIC ACIDEMIA IIC
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
An atlas of genetic influences on human blood metabolites.
|
24816252 |
2014 |
GLUTARIC ACIDEMIA IIC
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
|
25655951 |
2015 |
GLUTARIC ACIDEMIA IIC
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
GLUTARIC ACIDEMIA IIC, LATE-ONSET
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|